Research Technician I-II

Requisition number
1947
Employment Type
Regular Full-Time
Department
Harrison Lab
Job Type
Onsite
Location : Location
US-WA-Seattle

Overview

The Harrison Lab  is searching for a dedicated and motivated Research Technician I-II. The Research Technician will be responsible for providing technical laboratory support for biomedical research projects performing both routine and non-routine lab procedures.

Responsibilities

  • Preparing laboratory reagents, chemicals, stocks, cultures and cell lines
  • Basic molecular biology (cloning, plasmid isolation and transformation)
  • Production and purification of proteins
  • Working with mice, including immunization and surgeries if this is the focus of the project
  • Preparing samples from human blood, stool and tissue using sterile technique
  • Maintain laboratory records by recording detailed data, including photography and computer input, in a literate and thorough manner
  • Conduct lab inventory, complete purchase orders for hardware, glassware, and supplies

Qualifications

Research Tech I:

  • BA/BS in a scientific field and basic laboratory skills required
  • Must have basic mathematical, data recording, computer database, data and statistical analysis skills.
  • Prior work in a laboratory environment, especially multi-parameter flow cytometry, molecular biology or protein production, preferred

 

Research Tech II:

  • BA/BS in a scientific field and a minimum of 2-3 years work experience in a scientific research laboratory
  • Must have basic mathematical, data recording, computer database, data and statistical analysis skills.
  • Prior work in a laboratory environment, especially multi-parameter flow cytometry, molecular biology or protein production, preferred

Compensation

Research Tech I:

$22.46 to $31.89 per hr.

 

Research Tech II:

$25.90 to $38.07 per hr.

Benefits

  • Medical, dental, vision insurance
  • Flexible spending accounts: health care, dependent care, commuter
  • Short and long-term disability
  • Life and AD&D insurance
  • 403(b) retirement plan with matching funds after one year of employment
  • PTO: 13 holidays, three weeks of vacation and two weeks of sick leave per year
  • Employee assistance program
  • Educational assistance program
  • Subsidized ORCA pass
  • Wellness benefits
  • Voluntary benefits

About Us

Benaroya Research Institute (BRI) has a bold mission: To predict, prevent, reverse and cure immune system diseases, from autoimmune disease to cancer to COVID-19. We examine the immune system in both health and disease to understand how disorders start and how to rebalance the immune system back to health. Equipped with innovative tools and robust biorepositories, our team chips away at the biggest mysteries behind these conditions to work toward our vision of a healthy immune system for everyone. BRI is a world-renowned independent nonprofit research institute affiliated with Virginia Mason Franciscan Health and based in Seattle. We collaborate with clinicians to accelerate the path from innovative lab discoveries to life-changing patient care.

 

At BRI, each role is valued and an important contributor to our vision and mission. BRI is committed to a safe, caring and diverse workplace; as well as to taking action to further our commitment to foster inclusion, equity and belonging so employees feel comfortable bringing their full selves to work. Consider making a difference by joining our team. Because together, we are powering possibility.

 

To learn more, visit benaroyaresearch.org and connect with us on Facebook, Instagram, Threads,  LinkedIn, X and YouTube.
 

All qualified applicants will receive consideration for employment without regard to race, color, age, religion, sex, sexual orientation, gender identity, national origin, disability or protected veteran status.

 

If you need assistance completing the application process, please contact Human Resources at 206-342-6972 or email jobs@benaroyaresearch.org.

Options

Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
Share on your newsfeed